Neurescue

Focus: Neurescue is a Danish medical device company specializing in balloon catheter technology (REBOA) for cardiac arrest resuscitation. The company operates in a niche but critical cardiovascular emergency care segment.

Cardiovascular

Profile data last refreshed 5m ago · AI intelligence enriched 1w ago

Open Jobs

About Neurescue

AI assessmentNot Hiring

No open roles listed right now. Follow Neurescue to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

REBOA

Cardiac Arrest

N/A

Clinical Trials (1)

NCT04491903REBOA for Out-of-hospital Cardiac Arrest

N/A

Help build intelligence for Neurescue

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Work on a life-critical medical device addressing cardiac arrest, a high-mortality emergency condition with significant unmet clinical need.
Join a specialized cardiovascular device company with a focused pipeline and potential for meaningful clinical impact in emergency medicine.
Early-stage opportunity to shape product development and clinical strategy in an emerging therapeutic category (REBOA devices).

Watch Out For

No active job openings currently listed, suggesting limited near-term hiring or potential organizational constraints.
Sparse public data on funding, financials, employee count, and company maturity raises questions about stability and growth trajectory.
Pre-revenue device company with early-stage development (no marketed products) carries execution and capitalization risk.

Generated by Claude from Neurescue's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Advanced Cardiac Life Support

Cardiac Arrest (CA)

N/A

Clinical Trials (1)

NCT06793033A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support

N/A

NEURESCUE device

Cardiac Arrest

N/A

Clinical Trials (1)

NCT05444049NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

N/A

NEURESCUE device

Cardiac Arrest

N/A

Clinical Trials (1)

NCT05146661NEURESCUE Device as an Adjunct to Cardiac Arrest

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 4 clinical trials

Top TAs: Respiratory

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Respiratory

3 pipeline

Marketed

Pipeline